Lite Strategy, Inc. (LITS)

US — Healthcare Sector
Peers: TCRX  ACET  IMUX  PMVP  RLMD  NTRB  ACRV  HOWL  XBIT  IOBT 

Automate Your Wheel Strategy on LITS

With Tiblio's Option Bot, you can configure your own wheel strategy including LITS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol LITS
  • Rev/Share 0.0
  • Book/Share 2.9328
  • PB 0.7092
  • Debt/Equity 0.0
  • CurrentRatio 16.7843
  • ROIC -0.8933

 

  • MktCap 74162722.0
  • FreeCF/Share -4.4198
  • PFCF -2.5183
  • PE -0.8692
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -0.6408

 

  • Rating D+
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Lite Strategy, Inc. (LITS)

  • IPO Date 2003-12-18
  • Website https://www.litestrategy.com
  • Industry Biotechnology
  • CEO Anne Frese
  • Employees 4
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.